New drug 'staves off' Alzheimer's symptoms
Linkedin

New drug 'staves off' Alzheimer's symptoms

Dublin : Ireland | Oct 10, 2012 at 1:50 AM PDT
Source: Independent
XX XX
Views: Pending
 
Wednesday October 10 2012 A NEW drug could dramatically slow the onset of memory loss for people with Alzheimer's disease. Combined results from two trials showed that the drug, called solanezumab, slowed the speed of mental decline by a third in those with mild-to-moderate cases of the disease. FULL ARTICLE AT Independent
1 of 1
Alzheimer's disease
Alzheimer's disease
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 
  • Roche partners on hearing-loss drug

      Suburban Trends
    The drug maker said it has entered into an exclusive partnership with Versant Ventures and Inception Sciences to create a drug discovery incubator, Inception 3, for the treatment of sensorineural hearing loss. It is the most common type of permanent...
  • Roche, Lilly drugs set for Alzheimer's prevention trial

      Turks and Caicos Free Press
    A logo of Swiss pharmaceutical company Roche is pictured in front of a company's building in Rotkreuz, April 12, 2012. Experimental Alzheimer's drugs from Roche Holding AG and Eli Lilly & Co have been selected for a high-profile clinical trial to...
  • Roche, Lilly drugs chosen for Alzheimer's trial

      Reuters
    Topics A logo of Swiss pharmaceutical company Roche is pictured in front of a company's building in Rotkreuz, April 12, 2012. Experimental drugs from Roche Holding AG and Eli Lilly & Co have been selected for a global Alzheimer's disease prevention...
  • Eli Lilly announces phase 3 Solanezumab EXPEDITION studies results

      Pharmaceutical Industry News
    Rachelle Doody said, "These results represent an important step for the medical, academic, and scientific communities in understanding brain amyloid as a target of AD therapies."...In Lilly's pre-specified secondary analysis of pooled data in...

Images

 >
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.